| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
20,711 |
17,313 |
$2.91M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,485 |
18,705 |
$1.66M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,249 |
1,174 |
$695K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,479 |
3,994 |
$571K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,838 |
1,800 |
$443K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,271 |
851 |
$441K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,131 |
3,484 |
$390K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,495 |
5,026 |
$319K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,536 |
1,128 |
$296K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,705 |
1,539 |
$242K |
| 70450 |
Computed tomography, head or brain; without contrast material |
823 |
788 |
$240K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,198 |
1,131 |
$204K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,316 |
1,188 |
$201K |
| 99201 |
|
702 |
512 |
$184K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,184 |
2,887 |
$163K |
| J3490 |
Unclassified drugs |
12,381 |
8,135 |
$158K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,097 |
956 |
$156K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,468 |
2,104 |
$139K |
| 97139 |
|
2,279 |
552 |
$112K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,707 |
1,518 |
$105K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
664 |
642 |
$100K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,510 |
1,474 |
$95K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,128 |
1,022 |
$91K |
| 80053 |
Comprehensive metabolic panel |
8,488 |
7,382 |
$87K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
985 |
949 |
$86K |
| 71045 |
Radiologic examination, chest; single view |
2,732 |
2,505 |
$70K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,586 |
1,842 |
$66K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,693 |
8,320 |
$61K |
| 71046 |
Radiologic examination, chest; 2 views |
1,424 |
1,381 |
$59K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
555 |
543 |
$55K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,251 |
4,449 |
$55K |
| 76830 |
Ultrasound, transvaginal |
356 |
341 |
$53K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,211 |
612 |
$52K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,147 |
3,566 |
$36K |
| 81001 |
|
6,982 |
6,317 |
$31K |
| 97799 |
|
667 |
144 |
$31K |
| 73562 |
|
458 |
438 |
$29K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,127 |
2,894 |
$27K |
| 97750 |
|
250 |
172 |
$26K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
170 |
161 |
$25K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,389 |
3,032 |
$24K |
| 83690 |
|
3,913 |
3,486 |
$22K |
| 84484 |
|
2,686 |
2,092 |
$22K |
| 76642 |
|
147 |
137 |
$21K |
| 73610 |
|
298 |
285 |
$20K |
| 73630 |
|
265 |
251 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
676 |
613 |
$17K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,546 |
1,409 |
$15K |
| J2704 |
Injection, propofol, 10 mg |
1,218 |
1,039 |
$14K |
| 81025 |
|
4,003 |
3,638 |
$14K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,061 |
793 |
$12K |
| 0450 |
Emergency room services |
105 |
98 |
$11K |
| Z7502 |
|
265 |
263 |
$10K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
34 |
30 |
$10K |
| 82077 |
|
484 |
423 |
$9K |
| 73030 |
|
124 |
120 |
$9K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
128 |
118 |
$8K |
| 87040 |
|
612 |
342 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
177 |
164 |
$8K |
| 83605 |
|
724 |
568 |
$6K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
43 |
38 |
$6K |
| 73130 |
|
71 |
68 |
$5K |
| 85610 |
|
1,558 |
1,414 |
$5K |
| J2060 |
Injection, lorazepam, 2 mg |
690 |
571 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
684 |
628 |
$4K |
| 76536 |
|
43 |
42 |
$4K |
| 83735 |
|
689 |
597 |
$3K |
| 87430 |
|
310 |
309 |
$3K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
26 |
26 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
380 |
311 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
484 |
425 |
$3K |
| 87400 |
|
362 |
361 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
320 |
280 |
$3K |
| 87077 |
|
307 |
273 |
$3K |
| 87186 |
|
292 |
271 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
87 |
64 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
79 |
75 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
79 |
75 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
379 |
347 |
$2K |
| 87081 |
|
224 |
222 |
$2K |
| 83880 |
|
73 |
69 |
$2K |
| 73110 |
|
30 |
28 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
278 |
225 |
$1K |
| 73080 |
|
15 |
14 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
100 |
87 |
$1K |
| 82947 |
|
315 |
275 |
$1K |
| 73140 |
|
29 |
27 |
$1K |
| 85730 |
|
260 |
237 |
$1K |
| 72100 |
|
14 |
12 |
$917.76 |
| 85379 |
|
78 |
75 |
$553.10 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
104 |
95 |
$494.32 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
63 |
53 |
$475.76 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
60 |
54 |
$372.36 |
| 81003 |
|
173 |
172 |
$269.88 |
| 87420 |
|
66 |
59 |
$147.42 |
| S0028 |
Injection, famotidine, 20 mg |
26 |
25 |
$139.10 |
| 86900 |
|
47 |
39 |
$99.76 |
| 86901 |
|
47 |
39 |
$97.53 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
14 |
12 |
$97.28 |
| 87205 |
|
28 |
28 |
$94.16 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
26 |
26 |
$68.23 |
| 86140 |
|
15 |
13 |
$64.82 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
16 |
12 |
$61.50 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
112 |
105 |
$2.16 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
13 |
$1.95 |